Alaunos Therapeutics, Inc.
TCRT
Revenue
4.00k
▲3.00k▲300.00%
3 Months ChangeAssets
4.68M
▼-1.36M▼-22.51%
3 Months ChangeLiabilities
907.00k
▼-333.00k▼-26.85%
3 Months ChangeFree Cash Flow
-1.92M
▲7.53M▲79.70%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-10
Form 8-K
ID: 0000950170-24-113960
2024-08-14
Form 10-Q
ID: 0000950170-24-097142
2024-07-16
Form 8-K
ID: 0000950170-24-083765
2024-07-16
Form 8-K
ID: 0000950170-24-083764
2024-06-21
Form 8-K
ID: 0000950170-24-076333
2024-06-12
Form 8-K
ID: 0000950170-24-072534
2024-05-15
Form 10-Q
ID: 0000950170-24-060075
2024-02-22
Form 8-K
ID: 0001193125-24-042903
2024-02-20
Form 8-K
ID: 0001193805-24-000251
2024-02-01
Form 8-K
ID: 0001193805-24-000111